BR112012000804B8 - composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água - Google Patents

composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água

Info

Publication number
BR112012000804B8
BR112012000804B8 BR112012000804A BR112012000804A BR112012000804B8 BR 112012000804 B8 BR112012000804 B8 BR 112012000804B8 BR 112012000804 A BR112012000804 A BR 112012000804A BR 112012000804 A BR112012000804 A BR 112012000804A BR 112012000804 B8 BR112012000804 B8 BR 112012000804B8
Authority
BR
Brazil
Prior art keywords
mixing
water
composition
kit
aqueous solution
Prior art date
Application number
BR112012000804A
Other languages
English (en)
Other versions
BR112012000804B1 (pt
BR112012000804A2 (pt
Inventor
Cockett Alasdair
Padfield Dawn
Cox Ian
Granger Janet
Attwell Mark
Padfield Nick
Oza Pankaj
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of BR112012000804A2 publication Critical patent/BR112012000804A2/pt
Publication of BR112012000804B1 publication Critical patent/BR112012000804B1/pt
Publication of BR112012000804B8 publication Critical patent/BR112012000804B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

composições, soluções e kit para limpeza de cólon, bem como método para tal e uso de componentes para preparação de solução. a presente invenção refere-se a uma composição seca para mistura com água, onde a composição é opcionalmente apresentada em duas ou mais partes e compreende, por litro de solução a ser aplicada, os seguintes componentes: (a) 85 a 115 g de polietileno glicol (peg) tendo um peso molecular médio de 2500 a 4500; (b) 6 a 9 g de sulfato de sódio; (c) 2 a 3 g 1 o de cloreto de sódio; (d) 0,5 a 1,5 g de cloreto de potássio; (e) 5 a 15 g de um componente ácido orgânico; e (f) aromatizante laranja. também são provi- das soluções, kits, doses unitárias e processos que compreendem ou usam as composições.
BR112012000804A 2009-07-17 2010-07-16 composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água BR112012000804B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0912487.6A GB0912487D0 (en) 2009-07-17 2009-07-17 Improvements in and relating to colon cleansing compositions
GB0912487.6 2009-07-17
US30581410P 2010-02-18 2010-02-18
US61/305,814 2010-02-18
PCT/GB2010/001362 WO2011007153A1 (en) 2009-07-17 2010-07-16 Improvements in and relating to colon cleansing compositions

Publications (3)

Publication Number Publication Date
BR112012000804A2 BR112012000804A2 (pt) 2016-02-23
BR112012000804B1 BR112012000804B1 (pt) 2021-03-30
BR112012000804B8 true BR112012000804B8 (pt) 2021-05-25

Family

ID=41058153

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012000804A BR112012000804B8 (pt) 2009-07-17 2010-07-16 composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água

Country Status (14)

Country Link
EP (1) EP2453873B1 (pt)
KR (2) KR20180012866A (pt)
AT (1) AT13208U1 (pt)
BR (1) BR112012000804B8 (pt)
CA (1) CA2768275C (pt)
EA (1) EA025767B1 (pt)
ES (1) ES2886335T3 (pt)
FR (1) FR2948029A1 (pt)
GB (2) GB0912487D0 (pt)
LU (1) LU91786B1 (pt)
NL (1) NL2005102C2 (pt)
NZ (1) NZ595785A (pt)
SG (1) SG178044A1 (pt)
WO (1) WO2011007153A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130189377A1 (en) * 2010-07-27 2013-07-25 Norgine Bv Compositions
EP2670391A1 (en) * 2011-01-31 2013-12-11 Norgine BV Improvements in and relating to compositions
TWI535461B (zh) * 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
JP6272776B2 (ja) * 2011-12-07 2018-01-31 エムエスエム イノベーションズ、インク． 腸管前処置のための方法
CA2919487A1 (en) * 2012-08-03 2014-02-06 Msm Innovations, Inc. Kits using miraculin to reduce salty taste of a liquid composition
HUE043605T2 (hu) 2012-09-11 2019-08-28 Norgine Bv PEG-et és aszkorbátot tartalmazó kompozíciók
KR20140044628A (ko) * 2012-10-05 2014-04-15 주식회사태준제약 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
KR20190093491A (ko) 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
RU2709495C1 (ru) * 2019-08-01 2019-12-18 Общество с ограниченной ответственностью "Гелеспон" Способ очищения кишечника и набор для его осуществления
TR201912004A2 (tr) * 2019-08-07 2021-02-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Poli̇eti̇len gli̇kol i̇çeren bi̇r saşe formülasyonu
CN111617102B (zh) * 2020-05-25 2022-05-31 南京金凯木纳米材料有限公司 一种含聚乙二醇的电解质散剂及其制备方法
KR20220033790A (ko) * 2020-09-10 2022-03-17 강윤식 장 정결용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224909D0 (en) * 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
WO2009052256A2 (en) * 2007-10-17 2009-04-23 Thomas Jefferson University Bowel purgative and uses thereof
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.

Also Published As

Publication number Publication date
SG178044A1 (en) 2012-03-29
CA2768275C (en) 2018-02-13
AT13208U1 (de) 2013-08-15
KR20120070560A (ko) 2012-06-29
CA2768275A1 (en) 2011-01-20
EP2453873A1 (en) 2012-05-23
KR20180012866A (ko) 2018-02-06
IE20100443A1 (en) 2011-02-16
AU2010272311B2 (en) 2016-02-11
WO2011007153A1 (en) 2011-01-20
WO2011007153A8 (en) 2011-03-10
GB2471954A (en) 2011-01-19
BR112012000804B1 (pt) 2021-03-30
ES2886335T3 (es) 2021-12-17
NL2005102A (en) 2011-01-18
NL2005102C2 (en) 2011-05-17
EA201200153A1 (ru) 2012-07-30
AU2010272311A1 (en) 2012-02-02
GB0912487D0 (en) 2009-08-26
GB201012038D0 (en) 2010-09-01
NZ595785A (en) 2014-09-26
FR2948029A1 (fr) 2011-01-21
BR112012000804A2 (pt) 2016-02-23
LU91786B1 (fr) 2011-06-02
EP2453873B1 (en) 2021-06-30
AU2010272311A8 (en) 2016-07-21
EA025767B1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
BR112012000804B8 (pt) composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água
IN2012DN00306A (pt)
BR112014029754B1 (pt) soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição
EA201001555A1 (ru) Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
ECSP109917A (es) Nuevos derivados de ácido azabifenilaminobenzoico
BRPI0911681B8 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
BR112013001039A2 (pt) método de limpeza dos cabelos
BR112015008912A2 (pt) composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
EA201001556A1 (ru) Соединения, включающие противовоспалительный фармакофор, и способы их применения
BR112012022775A2 (pt) composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas
BR112015006426A2 (pt) composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos
BR112013031471A2 (pt) composição de revestimento e método para uso da composição de revestimento
EA201071320A1 (ru) Активаторы глюкокиназы
CL2009000309A1 (es) Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2.
BR112015005270A8 (pt) composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit.
EA201171216A1 (ru) Фенилацетат l-орнитина и способы его получения
JP2011500711A5 (pt)
BRPI0916069C1 (pt) composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição
ECSP11011082A (es) Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos
BR112015004089A2 (pt) micro-organismos e métodos para intensificar a disponibilidade de equivalentes de redução na presença de metanol e para produzir 1,4-butanodiol relacionado com os mesmos
BR112016000839A8 (pt) composições compreendendo policlorossulfato de alumínio, seus processos de produção, embalagens e processo de tratamento de água
BR112016006064A2 (pt) composição de pró-dentifrício, composição com base em glicerina, e, kit para terapia da mucosa oral
UY33417A (es) Formulación que contiene acido azelaico con adición de pigmento
BR112012017994A2 (pt) composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF